Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

MagGraphZyme

Financiado

Design of novel Magnetic Graphene Oxide Nanozyme platform for Theranostic applic...

Design of novel Magnetic Graphene Oxide Nanozyme platform for Theranostic applications MagGraphZyme aims at the development of a new hybrid multiplatform capable of triggering the intracellular production of reactive oxygen/nitrogen species (ROS/RNS) for inducing cell death in cancer cells. The proposed hybrid nanos... ver más

31/05/2026

UNIZAR

261K€

Presupuesto del proyecto: 261K€

Líder del proyecto

UNIVERSIDAD DE ZARAGOZA. OFICINA DE TRANSFERE... No se ha especificado una descripción o un objeto social para esta compañía.

Sin perfil tecnológico

Ver 3 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2022-08-29

HORIZON-MSCA-2021-PF-01-01: MSCA Postdoctoral Fellowships 2021 ExpectedOutcome:

I+D

Cerrada hace 3 años

0% 100%

3 Participantes

UNIZAR

261.38K€ | Lider

RUTGERS, THE STATE UNIVERSIT...

RUTGERS

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PID2019-106229RB-I00 NANOESTRUCTURAS OPTO-MAGNETICAS PARA NANOTERAPIAS CON CONTRO... 218K€ Cerrado

CTQ2017-89416-R FUNCIONALIZACION DE NANOPARTICULAS DE ORO CON MARCADORES BIO... 71K€ Cerrado

PID2020-112685RB-I00 NANOMEDICINAS BASADAS EN NANOPARTICULAS PARA INMUNOTERAPIA E... 249K€ Cerrado

PCI2021-122027-2B NANOASSEMBLIES FOR MAGNETIC DELIVERY AND RELEASE OF CANCEROS... 161K€ Cerrado

TEC2016-80976-R CONTROL DE NANOPARTICULAS MAGNETICAS PARA TERAPIA GUIADA POR... 139K€ Cerrado

MAT2010-19326 NANOPARTICULAS MAGNETICAS PARA VECTORIZACION INTRACELULAR Y... 157K€ Cerrado

Duración del proyecto: 45 meses Fecha Inicio: 2022-08-29
Fecha Fin: 2026-05-31

Líder del proyecto

UNIVERSIDAD DE ZARAGOZA. OFICINA DE TRANSFERE... No se ha especificado una descripción o un objeto social para esta compañía.

Sin perfil tecnológico

Presupuesto del proyecto 261K€

Descripción del proyecto MagGraphZyme aims at the development of a new hybrid multiplatform capable of triggering the intracellular production of reactive oxygen/nitrogen species (ROS/RNS) for inducing cell death in cancer cells. The proposed hybrid nanosystem, based on the combination of magnetic nanoparticles (MNPs), nitrogen doped graphene oxide (N-GO) and a polymer (PLGA) shell, will improve ROS/RNS production due to the synergistic effects of all components regarding their catalytic activity as peroxidase-mimetic nanozymes. The control of this catalytic activity will be performed by heating the intracellular level via the activation of the constituent MNPs through a remotely applied magnetic field. Thus, a novel approach for intracellular ROS/RNS production and quantification will be implemented. Furthermore, with the aim of understanding the different cells’ pathways involved in the toxicity and the final death of the cells, these hybrid system will be evaluated to investigate pathway-specific ROS/RNS induction of apoptosis and ROS-response mechanisms. Thus, I will study signaling pathways which are known to be influenced by the production of these species. To this end, I propose detailed physical and chemical studies, down to the atomic level, of the MNPs@N-GO-PLGA systems for identifying the relationships between catalytic efficacy and active atomic sites within the structures. These works will be developed by a motivated researcher with a strong background in MNPs, who will enhance and diversify his skills in advanced microscopy techniques and will acquire competences in bio-medicine. This multidisciplinary and innovative proposal will strengthen the collaboration between the hosting institutions, will enable the European hosting institution to reinforce crucial competences in the understanding & production of multifunctional materials and will contribute to improving oncological applications, which is one of the most important scientific challenges with a high social impact.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores